ELOXX PHARMACEUTICALS, INC. Income Tax Expense
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Income Tax Expense of $0 for the 12-month period ending 2025-12-31, per its S-1 filed 2026-09-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2019-03-31 was $0.00.
- ELOXX PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2018-12-31 was $122.00K.
- ELOXX PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2018-09-30 was $0.00.
- ELOXX PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2022 was $0.00.
- ELOXX PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2021 was $0.00.
- ELOXX PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2020 was $0.00.
- ELOXX PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 S-1 · filed 2026-09-11 | ||||
| 2024-12-31 | $0.00 S-1 · filed 2026-09-11 | ||||
| 2023-12-31 | $0.00 S-1 · filed 2026-09-11 | ||||
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | ||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-30 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $122.00K derived: sum of 2 quarters · filed 2021-03-12 | $122.00K derived: sum of 3 quarters · filed 2021-03-12 | $122.00K derived: sum of 4 quarters · filed 2021-03-12 | |
| 2018-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $122.00K derived: sum of 2 quarters · filed 2021-03-12 | $122.00K derived: sum of 3 quarters · filed 2021-03-12 | $122.00K 10-K · filed 2021-03-12 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $0.00 10-Q · filed 2018-08-10 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | $400.00K derived: sum of 2 quarters · filed 2017-11-14 | $400.00K derived: sum of 3 quarters · filed 2017-11-14 | $0.00 derived: sum of 4 quarters · filed 2017-11-14 | |
| 2017-06-30 | $400.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2017-11-14 | $400.00K derived: sum of 2 quarters · filed 2017-11-14 | $0.00 derived: sum of 3 quarters · filed 2017-11-14 | -$640.00K 10-Q · filed 2017-11-14 | -$1.04M 10-K · filed 2017-10-13 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-22 | -$400.00K derived: sum of 2 quarters · filed 2017-05-22 | -$1.04M 10-Q · filed 2017-05-22 | -$1.32M derived: sum of 4 quarters · filed 2017-10-13 | |
| 2016-12-31 | -$400.00K 10-Q · filed 2017-02-10 | -$1.04M 10-Q · filed 2017-02-10 | -$1.32M derived: sum of 3 quarters · filed 2017-10-13 | -$1.72M derived: sum of 4 quarters · filed 2017-10-13 | |
| 2016-09-30 | -$640.00K 10-Q · filed 2016-11-14 | -$920.00K derived: sum of 2 quarters · filed 2017-10-13 | -$1.32M derived: sum of 3 quarters · filed 2017-10-13 | -$1.32M derived: sum of 4 quarters · filed 2017-10-13 | |
| 2016-06-30 | -$280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | -$680.00K derived: sum of 2 quarters · filed 2017-10-13 | -$680.00K derived: sum of 3 quarters · filed 2017-10-13 | -$680.00K 10-K · filed 2017-10-13 | |
| 2016-03-31 | -$400.00K 10-Q · filed 2017-05-22 | -$400.00K derived: sum of 2 quarters · filed 2017-05-22 | -$400.00K 10-Q · filed 2017-05-22 | -$400.00K derived: sum of 4 quarters · filed 2017-10-13 | |
| 2015-12-31 | $0.00 10-Q · filed 2017-02-10 | $0.00 10-Q · filed 2017-02-10 | $0.00 derived: sum of 3 quarters · filed 2017-10-13 | $0.00 derived: sum of 4 quarters · filed 2017-10-13 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-10-13 | $0.00 derived: sum of 3 quarters · filed 2017-10-13 | ||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | $0.00 derived: sum of 2 quarters · filed 2017-10-13 | $0.00 10-K · filed 2017-10-13 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-12 | $0.00 10-Q · filed 2016-05-12 | |||
| 2014-06-30 | $0.00 10-K · filed 2016-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |